(NASDAQ: TLRY) Tilray Brands's forecast annual revenue growth rate of 8.75% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 9.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.23%.
Tilray Brands's revenue in 2024 is $743,248,000.On average, 7 Wall Street analysts forecast TLRY's revenue for 2024 to be $607,552,043,802, with the lowest TLRY revenue forecast at $593,989,515,409, and the highest TLRY revenue forecast at $620,616,097,804. On average, 7 Wall Street analysts forecast TLRY's revenue for 2025 to be $670,626,856,965, with the lowest TLRY revenue forecast at $634,084,194,714, and the highest TLRY revenue forecast at $715,511,999,015.
In 2026, TLRY is forecast to generate $741,964,424,985 in revenue, with the lowest revenue forecast at $676,268,751,125 and the highest revenue forecast at $816,832,337,257.